Inventor · disambiguated record
Erica A. Golemis
Also filed as: GOLEMIS ERICA · GOLEMIS ERICA A
16 granted patents·8 pending applications·154 citations·filing 1991–2020
91Inventor score
Files withFOX CHASE CANCER CENTER5FOX CHASE CANCER CT5GEN HOSPITAL CORP2INSTITUTE FOR CANCER RES2RATUSHNY VLADIMIR2
Top patents by PatentIndex Score
24 records- 0193US7919610B2Yeast bacterial two-hybrid system and methods of use thereofFOX CHASE CANCER CT·Filed 2005·Granted Apr 5, 2011·27 cites·7 claims
- 0291US5580736AInteraction trap system for isolating novel proteinsGEN HOSPITAL CORP·Filed 1995·Granted Dec 3, 1996·85 cites·41 claims
- 0376US10724100B2Systems and methods for treating patients having a genetic predisposition to develop prostate cancerINSTITUTE FOR CANCER RES·Filed 2015·Granted Jul 28, 2020·2 cites·22 claims
- 0458US9101631B2Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancerRATUSHNY VLADIMIR·Filed 2009·Granted Aug 11, 2015·0 cites·13 claims
- 0557US10450613B2EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CENTER·Filed 2016·Granted Oct 22, 2019·0 cites·2 claims
- 0655US2010137409A1Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and RegulationPLOTNIKOVA OLGA V·Filed 2009·Application pending·0 cites
- 0754US5580721AAssays for inhibitors of myc oncoproteinGEN HOSPITAL CORP·Filed 1991·Granted Dec 3, 1996·22 cites·21 claims
- 0854US2021010087A1Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate CancerINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2020·Application pending·0 cites
- 0953US2013331294A1Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CT·Filed 2013·Application pending·0 cites
- 1052US6326150B1Yeast interaction trap assayFOX CHASE CANCER CT·Filed 1998·Granted Dec 4, 2001·15 cites·21 claims
- 1151US7705021B2Isoindolone compounds, compositions containing the same, and methods of use thereof for the treatment of viral infections related to the etiology of cancerFOX CHASE CANCER CT·Filed 2006·Granted Apr 27, 2010·0 cites·11 claims
- 1251US2021386877A1Radiotherapeutic combination therapy for the treatment of cancerANDARIX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1350US8685658B2Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulationGOLEMIS ERICA A·Filed 2007·Granted Apr 1, 2014·0 cites·8 claims
- 1448US2011033461A1Combination Therapy for the Treatment of CancerRATUSHNY VLADIMIR·Filed 2009·Application pending·0 cites
- 1545US2003211495A1Reverse n-hybrid screening methodFiled 2001·Application pending·0 cites
- 1642US11578370B2Methods for diagnosis and treatment of patients having solid tumorsINSTITUTE FOR CANCER RES·Filed 2018·Granted Feb 14, 2023·0 cites·11 claims
- 1742US9677072B2Methods of inhibiting proliferation of estrogen-independent cancer cellsWEINER LOUIS M·Filed 2012·Granted Jun 13, 2017·0 cites·3 claims
- 1842US2015283147A1Treating polycystic kidney disease with hsp90 inhibitory compoundsSYNTA PHARMACEUTICALS CORP·Filed 2013·Application pending·0 cites
- 1938US2010239656A1Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersASTSATUROV IGOR·Filed 2010·Application pending·0 cites
- 2037US6653074B1Methods for identifying agents which affect cellular morphology, locomotion and deathFOX CHASE CANCER CT·Filed 2000·Granted Nov 25, 2003·0 cites·4 claims
- 2134US5770717ANucleic acid encoding a stress-responsive subunit of human RNA polymerase IIFOX CHASE CANCER CENTER·Filed 1995·Granted Jun 23, 1998·2 cites·11 claims
- 2232US5716782ANucleic acid encoding a signal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1995·Granted Feb 10, 1998·1 cites·17 claims
- 2328US6124434ASignal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1998·Granted Sep 26, 2000·0 cites·5 claims
- 2428US6100384AAntibodies immunologically specific for a signal mediator protein that induces cellular morphological alterationsFOX CHASE CANCER CENTER·Filed 1997·Granted Aug 8, 2000·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Erica A. Golemis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →